DTIL
PRECISION BIOSCIENCES INC · Healthcare
Insider Buying
$47K
reported purchases (SEC code P)
Insider Selling
$466K
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
May 22, 2026
SMITH J. JEFFERSON
PRECISION BIOSCIENCES INC (DTIL) has 20 SEC Form 4 filings (39 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: May 22, 2026.
Inside the rolling window, 7 insiders at PRECISION BIOSCIENCES INC reported 4 open-market purchases totaling $47K and 11 open-market sales totaling $466K. The most active filer is President and CEO Amoroso Michael with 3 filings. Insiders have net sold $398K over the trailing 6 months. The most recent open-market filing is a sale of 4,925 shares by Chief Research Officer SMITH J. JEFFERSON, dated Feb 18, 2026, worth $19K.
- Industry:Biotechnology
- CEO:Michael Amoroso
- Employees:67
- HQ:Durham, NC, US
- IPO:2019-03-28
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Research Officer | Sale | 4,925 | $19K | Feb 19 | +109.9% | SEC ↗ | |
| President and CEO | Sale | 20,559 | $79K | Feb 19 | +109.9% | SEC ↗ | |
| Chief Financial Officer | Sale | 8,149 | $31K | Feb 19 | +109.9% | SEC ↗ | |
| General Counsel and Secretary | Sale | 4,925 | $19K | Feb 19 | +109.9% | SEC ↗ | |
| Chief Financial Officer | Sale | 15,213 | $61K | Jan 22 | +93.6% | SEC ↗ | |
| General Counsel and Secretary | Sale | 8,854 | $36K | Jan 22 | +93.6% | SEC ↗ | |
SMITH J. JEFFERSONFirst filing | Chief Research Officer | Sale | 10,200 | $41K | Jan 22 | +93.6% | SEC ↗ |
| President and CEO | Sale | 34,799 | $145K | Jan 22 | +93.6% | SEC ↗ | |
Germano Geno JFirst filing | Director | Purchase | 3,000 | $14K | Dec 17 | +72.9% | SEC ↗ |
Brown MelindaFirst filing | Director | Purchase | 1,381 | $7K | Dec 17 | +72.9% | SEC ↗ |
| Director | Purchase | 2,700 | $13K | Dec 17 | — | SEC ↗ | |
Scimeca DarioFirst filing | General Counsel and Secretary | Sale | 665 | $4K | Nov 4 | — | SEC ↗ |
Amoroso MichaelFirst filing | President and CEO | Sale | 3,409 | $22K | Nov 4 | — | SEC ↗ |
Kelly John AlexanderFirst filing | Chief Financial Officer | Sale | 1,303 | $8K | Nov 4 | — | SEC ↗ |
Frankel StanleyFirst filing | Director | Purchase | 2,700 | $13K | Sep 30 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does DTIL have?
PRECISION BIOSCIENCES INC (DTIL) has 20 SEC Form 4 filings (39 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: May 22, 2026.
When was the most recent SEC Form 4 filing for DTIL?
The most recent Form 4 filing for DTIL on Tracefour is dated May 22, 2026.
Who is the most active insider at DTIL?
The most active SEC Form 4 filer at DTIL in the rolling window is President and CEO Amoroso Michael, with 3 filings.
What is the net insider flow at DTIL over the last 6 months?
Over the trailing 180 days, insiders at DTIL have net sold $398K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at DTIL in the current window?
Inside the rolling window, insiders at DTIL bought $47K and sold $466K based on SEC Form 4 filings.
Can I get alerts for DTIL insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at PRECISION BIOSCIENCES INC (DTIL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
PRECISION BIOSCIENCES INC is in the Healthcare sector.